Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Masimo's MightySat Medical is the first FDA-cleared pulse oximeter available to consumers without a prescription, which could disrupt the market for the notoriously inaccurate at-home devices.
MediView’s technologies utilize AR to provide clinicians with 3D “X-ray vision” guidance during minimally invasive procedures and surgeries, while also offering remote collaboration.
Aetna, in collaboration with Apple, launched a new health application to provide users with personalized health goals. Dubbed Attain, the app will be used in partnership with the Apple Watch to track daily activity levels, recommend healthy actions and incentivize actions taken to improve well-being.
Scientists at the University of Cambridge are developing a machine learning tool to better predict individuals’ long-term risk of developing cardiovascular disease (CVD)—specifically, heart attack or stroke.
Google’s AI tool for diagnosing diabetic retinopathy is having trouble reading images while it's being tested in an Indian hospital, according to a report by The Wall Street Journal.
In order for AI technology to be safely incorporated into diagnostic and clinical decision support (CDS) software, stakeholders must first address its effectiveness and provide additional evidence for its usefulness in the clinical setting, according to Duke researchers.
Though AI continues to make great strides within radiology, some radiologists are still unprepared to educate medical students regarding its usage. This in turn may hinder medical students and trainees from pursuing radiology, according to a new editorial published in Academic Radiology.
A new not-for-profit startup aimed at producing generic drugs will introduce 20 products in 2019, Reuters reported. The supplier, Civica Rx, initially expected to offer just 14 drugs in 2019, but will now likely exceed that after working with companies to produce additional medicines, company officials told Reuters.
Planned Parenthood is now offering an AI-powered, sexual health chatbot designed to reach more young people who visit its website, the organization announced Thursday, Jan. 24.
